CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥12.38T
P/E ratio
26.8x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
Period EndGross margin (%) YoY (%)
Dec 31, 202571.1+0.12%
Dec 31, 202471+13.05%
Dec 31, 202362.8+0.98%
Dec 31, 202262.2-6.01%
Dec 31, 202166.2+1.42%
Dec 31, 202065.2+6.57%
Dec 31, 201961.2+15.51%
Dec 31, 201853+4.56%
Dec 31, 201750.7+2.99%
Dec 31, 201649.2-1.54%
Dec 31, 201550-2.86%
Dec 31, 201451.5
AI Chat